High-Dose Platinum Combination Therapy in Pretreated Patients with Disseminated Melanoma

Publisher： Karger

E-ISSN： 1421-9794|53|6|422-428

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.6, 2007-10, pp. : 422-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma

By Pettijohn Erin   Martone Brenda   Rademaker Alfred   Kuzel Timothy  

Journal of Personalized Medicine, Vol. 4, Iss. 4, 2014-10 ,pp. : 448-458

MDPI

Access to resources Recommend Favorite

Long-Term Outcomes and Prognostic Factors of High-Risk Malignant Melanoma Patients after Surgery and Adjuvant High-Dose Interferon Treatment: A Single-Center Experience

By  

Chemotherapy, Vol. 60, Iss. 4, 2015-04 ,pp. : 228-238

Karger

Access to resources Recommend Favorite

Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination

By  

Chemotherapy, Vol. 57, Iss. 3, 2011-05 ,pp. : 217-224

Karger

Access to resources Recommend Favorite

Prospective Study of Vinorelbine and Capecitabine Combination Therapy in Chinese Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

By  

Chemotherapy, Vol. 56, Iss. 4, 2010-08 ,pp. : 340-347

Karger

Access to resources Recommend Favorite

Pharmacokinetics of High-Dose Meropenem in Adult Cystic Fibrosis Patients

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-04 ,pp. : 153-156

Karger

Access to resources Recommend Favorite